Legal Representation
Attorney
Joshua S. Jarvis, Esq.
USPTO Deadlines
Next Deadline
136 days remaining
NOA E-Mailed - SOU Required
Due Date
May 12, 2026
Extension Available
Until November 12, 2026
Application History
37 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 30, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Oct 29, 2025 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Oct 29, 2025 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Oct 29, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Oct 8, 2025 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Oct 8, 2025 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Oct 8, 2025 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Oct 8, 2025 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Oct 8, 2025 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| May 13, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| May 12, 2025 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| May 12, 2025 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| May 12, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Nov 12, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Sep 17, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Sep 17, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Aug 28, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Aug 12, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Aug 12, 2024 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Aug 12, 2024 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Aug 12, 2024 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Aug 12, 2024 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Jul 2, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jul 2, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jul 2, 2024 | ERFR | I | TEAS REQUEST FOR RECONSIDERATION RECEIVED | Loading... |
| Jun 10, 2024 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| Jun 10, 2024 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Jun 10, 2024 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| May 1, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| May 1, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| May 1, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Mar 27, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Mar 27, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Mar 27, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Mar 13, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jul 31, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jul 1, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Medication for the treatment of sexual dysfunction
Class 042
Scientific research; Scientific research and development; Scientific investigations for medical purposes; Medical and scientific research in the field of treatment of sexual dysfunction, sexual organs-related disorders, drug delivery to sexual organs, discovery and development of medications for the treatment of sexual dysfunctions, conducting clinical trials for others to determine efficacy of treatments of sexual dysfunctions; Scientific research for medical purposes in the field of female sexual dysfunction, sexual organs-related disorders, drug delivery to sexual organs, discovery and development of medications for the treatment of sexual dysfunctions; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Medical research
Classification
International Classes
005
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"MEDICAL"